Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient (VITRECAT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02783209 |
|
Recruitment Status :
Terminated
(Major difficulties of patient inclusions)
First Posted : May 26, 2016
Last Update Posted : February 5, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Cataract Vitreous Detachment | Procedure: Cataract surgery | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 30 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient |
| Actual Study Start Date : | December 2014 |
| Actual Primary Completion Date : | February 1, 2018 |
| Actual Study Completion Date : | February 1, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Cataract surgery
Patient acts as his own control
|
Procedure: Cataract surgery |
- Occurence of vitreous detachment in the operated eye [ Time Frame: 3 months after the cataract surgery ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult emmetropic patient
- Without complete posterior vitreus detachment in both eyes before having surgery.
Exclusion Criteria:
- Diabetic retinopathy
- Ophthalmological treatment in progress
- History of ophthalmological surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02783209
| France | |
| URC Fondation Ophtalmologique A de Rothschild | |
| Paris, France, 75019 | |
| Responsible Party: | Fondation Ophtalmologique Adolphe de Rothschild |
| ClinicalTrials.gov Identifier: | NCT02783209 |
| Other Study ID Numbers: |
FME_2014_5 |
| First Posted: | May 26, 2016 Key Record Dates |
| Last Update Posted: | February 5, 2018 |
| Last Verified: | February 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Cataract Vitreous Detachment Lens Diseases Eye Diseases |

